Biolive, the turkish startup that signed a global sales contract with Global Eco Plastic

Biolive is a biotechnology company that produces and sells internationally patented and US Food and Drug Administration approved antimicrobial and antioxidant bioplastic granules, aimed as a replacement for petroleum-derived plastics, made from olive seeds – the first company in the world to do so. Biolive utilises olive oil production process waste which is normally discarded. Biolive granules are recyclable, have higher product characteristics and are more cost-effective than existing bioplastics and are produced in a low carbon and water footprint process. All research and testing have now been completed, and large-scale production of its bioplastic granules, at Biolive’s own production facility, is due to start in August 2022.

Biolive bioplastic granules’ have been tried and tested for use in numerous industries and have potential in many other fields including medical equipment. Biolive’s unique innovative product has been internationally recognised through over 30 global awards, including the 2019 EIT Food Innovation Prize. It has also attracted increasing attention from global investors and clients alike. Biolive recently signed a global sales contract with Global Eco Plastic while its product trials have reached more than 80 customers including Difaş, Allmug, Anadolu Efes and Vestel.

Since 2019 Biolive has received significant support from EIT Food, including smart financing, in-depth business mentorships and networking support. In particular, Biolive has credited EIT Food with helping it scale up its operation by introducing it to new customers from new sectors, investors and supporting its establishment of strategic partnerships.

EIT Food additionally provided Biolive with public exposure, including the Innovation Prize, which contributed its international recognition.